Patent classifications
A61B5/4244
Breath test device and method
There is provided a method of evaluating a liver condition of a subject, the method includes computing a fluctuation parameter from a liver breath test based on at least one of a percentage dose recovery (PDR) curve and a delta over baseline (DOB) curve of an isotope labeled methacetin, or a salt or a derivative thereof, and evaluating at least one liver condition of the subject, based at least on the fluctuation parameter. There is provided herein a method of evaluating a liver condition of a subject, the method includes computing a hepatic impairment score based at least on a breath test related parameter and on a demographic parameter.
NEUROMODULATION TECHNIQUES FOR PERTURBATION OF PHYSIOLOGICAL SYSTEMS
Embodiments of the present disclosure relate to techniques for inducing physiological perturbations in a subject via neuromodulation, e.g., peripheral neuromodulation of a region of interest of an organ. The nature and degree of the perturbations may be related to the subject's clinical condition. Accordingly, an assessment of one or more characteristics of the perturbations may be used to determine a clinical condition of the subject.
ELDERLY MORTALITY AFTER TRAUMA PREDICTION SYSTEM WITH MULTI-STAGE MODELLING AND REPORTING
An elderly-mortality prediction system includes a computing system configured to apply a first analytical model to a subset of a set of patient data parameters for computing a quick elderly mortality after trauma (qEMAT) score indicative of a likelihood of mortality of the patient, wherein the subset of the data parameters includes patient data available at admission of the patient, and further configured to apply a second analytical model to compute a full elderly mortality after trauma (fEMAT) score as an updated score indicative of a likelihood of mortality of the patient, using a full set of patient demographic data parameters including the subset of the data parameters available at admission of the patient and additional data parameters based upon diagnostic results and medical history of the patient.
Image based bilirubin determination
The invention relates to diagnosis in general and more specifically a system and a method for determining the presence of jaundice in newborn babies, also known as neonatal jaundice. A main objective of the present invention is to provide a simple system and method for determining the presence of jaundice. Particularly since most deaths due to jaundice occur in low-income countries, there is a large unmet need of simple, reliable and affordable technologies able to identify at-risk newborn. The objective is accomplished through receiving a depiction of skin from an RGB sensor, and then using either an optical diffusion model of the skin or Monte Carlo simulations to calculate the bilirubin concentration. A meta model of the optical diffusion model or Monte Carlo simulations can also be used. Colour calibration is also performed by e.g. thin-plate spline interpolation.
System and method for image processing with highly undersampled imaging data
A system and method for processing highly undersampled multi-echo spin-echo data by linearizing the slice-resolved extended phase graph model generates highly accurate T.sub.2 maps with indirect echo compensation. Principal components are used to linearize the signal model to estimate the T.sub.2 decay curves which can be fitted to the slice-resolved model for T2 estimation. In another example of image processing for highly undersampled data, a joint bi-exponential fitting process can compensate for image variations within a voxel and thus provide partial voxel compensation to produce more accurate T.sub.2 maps.
System that assesses health condition by measuring pulse and method of assessing the same
A system that assesses health condition by measuring pulse includes: a pulse measuring device that measures an artery of a user who receives assessment of health condition; a terminal that has a function that transmits measured-value data on pulse measured by the pulse measuring device to a health assessing administrator and receives information from the health assessing administrator; an administrative server that is administered by the health assessing administrator, analyzes the measured-value data transmitted from the terminal, and stores various data on health condition that is necessary to assess and analyze health condition. The user transmits the measured-value data on measured pulse from the terminal to the health assessing administrator, and the health assessing administrator transmits assessment information on health condition analyzed by the administrative server to the terminal.
INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters such as vital signs, methemoglobin levels, pulmonary function parameters, blood chemistry and hematological parameters, blood coagulation parameters, inflammatory marker levels, liver and kidney function parameters and vascular endothelial activation parameters, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.
Quantification device for lipid and/or protein levels in hepatic tissue
A quantification device for the level of lipids and/or proteins present within hepatic tissues. The Device includes: a light source, having at least one vacuum tungsten lamp with a total power of between 0.5 and 2 watts, with a total brightness of between 1000 and 2000 lumens and a total color temperature of between 6000 and 10000 degrees Kelvin; a photosensitive sensor having a sensitivity wavelength of between 800 nm and 2450 nm, configured to capture the light emitted from the light source after diffraction within liver tissues; means for extracting a diffraction spectrum of the light according to an image captured by the photosensitive sensor; and means for analyzing the spectrum in order to determine a level of lipids and/or proteins.
RADIO FREQUENCY ABLATION SYSTEMS
The present invention relates to systems for use for radio frequency ablation. The systems can include one or more of an ablation tool, power source for use with the ablation tool and a backstop for use in conjunction with the ablation tool during surgical procedures. Preferred ablation tools comprise a series of three or more blade-shaped electrodes disposed in a linear, curved, curvilinear or circular array. The backstops are useful for reducing direct physical and thermal heat transfer injuries to the patient or surgeon during procedures using radiofrequency (RF) ablation devices.
Volumetric Induction Phase Shift Detection System for Determining Tissue Water Content Properties
A method and apparatus of determining the condition of a bulk tissue sample, by: positioning a bulk tissue sample between a pair of induction coils (or antennae); passing a spectrum of alternating current (or voltage) through a first of the induction coils (or antennae); measuring spectrum of alternating current (or voltage) produced in the second of the induction coils (or antennae); and comparing the phase shift between the spectrum of alternating currents (or voltages) in the first and second induction coils (or antennae), thereby determining the condition of the bulk tissue sample.